Design and characterization of #HIV-1 #vaccine candidates to elicit antibodies targeting multiple epitopes. From Gristick, @bjorkman-lab.bsky.social et al.: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Structural and genetic basis of #HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. From Roark, Habib, Shaw, Kwong, Shapiro et al.: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect. From Kyle Rhodehouse, Robert F. Siliciano and colleagues: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Transcription of #HIV-1 is heterogenous among authentic latent CD4+ T cell clones, say Cintia Bittar, Michel C. Nussenzweig and colleagues: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Deconvoluting the interplay of innate & adaptive immunity in BCG-induced nonspecific & #TB-specific host resistance. Perspective by @kerryhilligan.bsky.social et al rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Noncanonical T cell responses are associated with protection from #tuberculosis in mice and humans. From Proulx, Wiggins, Lauffenburger, Sassetti et al. rupress.org/jem/article/...
📘 Updates on the Immune Responses to #TB and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Early and opposing #neutrophil and CD4 T cell responses shape pulmonary #tuberculosis pathology. From @bengern.bsky.social, Michael Gerner, Kevin Urdahl et al. rupress.org/jem/article/...
📘 Updates on the Immune Responses to #TB and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Type I IFN drives #neutrophil swarming, impeding lung T cell–#macrophage interactions and #TB control. From William Branchett, Anne O’Garra and colleagues: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Human CD4+ T cells recognize Mycobacterium #tuberculosis–infected #macrophages amid broader responses, from Stetsenko, Gail, Carpenter et al. rupress.org/jem/article/...
📘 Updates on the Immune Responses to #TB and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Single-cell and spatial profiling highlights #TB-induced myofibroblasts as drivers of lung pathology. From Ian Mbano and colleagues @ahri-news.bsky.social rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
This collection highlights recent JEM studies investigating the adaptive and innate immune response induced by M. #tuberculosis and HIV-1 infection. Read new findings to accompany @keystonesymposia.bsky.social meetings on #TB and #HIV Vaccines: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
🚨 Save $250 by Feb 17 (11:59 PM MST)!
Join the joint Keystone Symposia on Decoding HIV Persistence / HIV Vaccines and connect with cross-disciplinary leaders advancing preventive & therapeutic HIV strategies.
Register now:
keysym.us/KSHIVCure26
keysym.us/KSHIVVax26
#KSHIVCure26 #KSHIVVax26
Deadlines approaching for the joint Keystone Symposium Decoding HIV Persistence / HIV Vaccines.
Submit your short talk abstract or apply for a scholarship by Jan. 6 (11:59 pm MST) to secure your spot at this key meeting.
Apply now:
hubs.la/Q03Zfw1S0
hubs.la/Q03Zfv_10
#KSHIVCure26 #KSHIVVax26
